Helsinn Therapeutics (U.s.), Inc.
Woodbridge Township, NJ Doing business as Helsinn Therapeutics US Inc.
- UEI
- H7RDUVXHP8L3
- CAGE
- 7UCK3
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 200 S Wood Ave #100, Iselin, NJ 08830, USA
- Website
- helsinn.com
- Founded
- 1976
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| FY26-pharmacy valchlor GEL | Federal Correctional Institution Fort Worth | $5,985 | |
| FY26-pharmacy valchlor GEL | Federal Correctional Institution Fort Worth | $5,985 | |
| FY26-pharmacy valchlor GEL | Federal Correctional Institution Fort Worth | $5,985 | |
| FY26-pharmacy valchlor GEL | Federal Correctional Institution Fort Worth | $5,985 | |
| FY26-pharmacy valchlor GEL | Federal Correctional Institution Fort Worth | $5,985 |
About Helsinn Therapeutics (U.s.), Inc.
Helsinn Therapeutics (U.S.), Inc., doing business as Helsinn Therapeutics US Inc., supplies VALCHLOR gel, a specialized oncology pharmaceutical for cutaneous T-cell lymphoma treatment, to federal agencies as a prime contractor under GSA Schedule and Blanket Purchase Agreement vehicles, with no subcontracting footprint and no set-aside posture.
Helsinn is a for-profit pharmaceutical manufacturer headquartered in Iselin, New Jersey, competing under full-and-open federal procurement with no SBA designations. The company specializes in pharmaceutical preparation manufacturing (NAICS 339991 / PSC Drugs and Biologicals), with a federal portfolio concentrated almost entirely on VALCHLOR supply across two core vehicles: the Pharmaceuticals and Drugs (FSS-61-IB) General Services Administration Schedule, which carries a $33.57 million ceiling through February 2030, and a single-award Blanket Purchase Agreement with the Department of Veterans Affairs National Acquisition Center bearing an $8.34 million ceiling through March 2027. Recent delivery orders under the GSA Schedule include six orders from Federal Correctional Institution Fort Worth ($5,984.59 each, April through September 2026), one from Federal Medical Center Carswell ($5,984.59, January 2026), and one from Veterans Integrated Service Network 5 ($14,559.84, August 2025).
The vendor's customer base is dominated by the Department of Veterans Affairs. By potential value, VA controls 100% of dollars across three buying offices: Veterans Integrated Service Network 12 (3 awards, $36.9 million), the National Acquisition Center (3 awards, $28.2 million), and Veterans Integrated Service Network 6 (3 awards, $109 thousand). By award count, however, the Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth places the plurality of recent orders (6 awards, $36 thousand combined), reflecting small, recurring delivery-order volumes compared to the larger VA BPA ceiling values. The source data span nine years (first award May 2017) but show recent acceleration: seven awards in 2026 alone versus two to three awards per year in prior years.
Helsinn operates exclusively as a prime contractor (100% of recent awards) with no recorded subcontracting. Work is performed at the company's Iselin, New Jersey facility with distribution to federal healthcare facilities nationwide. The $18 thousand in awards completing within the next twenty-four months represents minimal recompete exposure relative to the $65.3 million combined potential value of the full portfolio, though the larger VA BPA ceiling values and the GSA Schedule contract itself do not face near-term expiration within that window. Helsinn's federal positioning rests on a single product with recurring procurement through established indefinite delivery vehicles rather than competitive task-order competition or broad service diversification.
Contract vehicles
Quick answers
What is Helsinn Therapeutics (U.s.), Inc.'s UEI?
Helsinn Therapeutics (U.s.), Inc.'s Unique Entity ID (UEI) in SAM.gov is H7RDUVXHP8L3.
What is Helsinn Therapeutics (U.s.), Inc.'s CAGE code?
Helsinn Therapeutics (U.s.), Inc.'s CAGE code is 7UCK3.
What is Helsinn Therapeutics (U.s.), Inc.'s primary NAICS code?
Helsinn Therapeutics (U.s.), Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Helsinn Therapeutics (U.s.), Inc. located?
Helsinn Therapeutics (U.s.), Inc.'s physical address in SAM.gov is 200 S Wood Ave #100, Iselin, NJ 08830, USA.
Is Helsinn Therapeutics (U.s.), Inc. registered in SAM.gov?
Yes. Helsinn Therapeutics (U.s.), Inc.'s SAM.gov registration is active through June 5, 2027.
Which contract vehicles does Helsinn Therapeutics (U.s.), Inc. hold?
Helsinn Therapeutics (U.s.), Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Helsinn Therapeutics (U.s.), Inc.'s most recent federal award?
Helsinn Therapeutics (U.s.), Inc.'s most recent federal contract award is FY26-pharmacy valchlor GEL (15B50926F00000087), from Federal Correctional Institution Fort Worth, on September 1, 2026.
On GovTribe
See Helsinn Therapeutics (U.s.), Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors